EUVIMEDEUVIMED entdecken
Editorial

Commentary; The ACTIVE trial (Snow et al.). Why did it take so long for ACI to be approved for use in the UK?

Norman Waugh

Osteoarthritis and Cartilage · 2026-08 · 34 (8) · 1150-1152

DOI: 10.1016/j.joca.2026.05.007 ↗

Kurz gefasst

Editorial in der Zeitschrift Osteoarthritis and Cartilage, 2026-08. Verfasst von Norman Waugh. Beteiligte Einrichtung: Division of Applied Health Sciences, University of Aberdeen, Aberdeen, UK. Electronic address: n.r.waugh@abdn.ac.uk. Die Arbeit nennt 15 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Division of Applied Health Sciences, University of Aberdeen, Aberdeen, UK. Electronic address: n.r.waugh@abdn.ac.uk.

Zitieren

APA

Waugh, N. (2026). Commentary; The ACTIVE trial (Snow et al.). Why did it take so long for ACI to be approved for use in the UK?. Osteoarthritis and Cartilage, 34(8), 1150-1152. https://doi.org/10.1016/j.joca.2026.05.007

Vancouver

Waugh N. Commentary; The ACTIVE trial (Snow et al.). Why did it take so long for ACI to be approved for use in the UK?. Osteoarthritis and Cartilage. 2026;34(8):1150-1152. doi:10.1016/j.joca.2026.05.007

BibTeX
@article{Waugh2026,
  author = {Waugh, Norman},
  title = {Commentary; The ACTIVE trial (Snow et al.). Why did it take so long for ACI to be approved for use in the UK?},
  journal = {Osteoarthritis and Cartilage},
  year = {2026},
  volume = {34},
  number = {8},
  pages = {1150--1152},
  doi = {10.1016/j.joca.2026.05.007}
}
Kostenlos starten →